Jump to Content Jump to Main Navigation

Volume 13 (2015): Issue 11 (Nov 2015)

in Journal of the National Comprehensive Cancer Network

Online ISSN:: 1540-1413

Print ISSN:: 1540-1405

NCCN News

Pages: xxxiii–xxxix
Oncology Research Program

Pages: xliv
At Last: Getting Paid to Think!

By: Margaret Tempero

Pages: 1297
Multidisciplinary Care: For the Sake of Our Patients

By: Christopher K. Bichakjian

Pages: 1299–1300
Buying In

By: Rodger J. Winn

Pages: 1301–1302
Ewing Sarcoma in a Patient With Cowden Syndrome

By: Mod C. Chandhanayingyong, Nicholas M. Bernthal, Piti Ungarreevittaya, Scott D. Nelson, Sant P. Chawla and Arun S. Singh

Pages: 1310–1314
Uterine Sarcoma, Version 1.2016

By: Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, Kathleen R. Cho, Christina Chu, David Cohn, Marta Ann Crispens, Don S. Dizon, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Suzanne George, Ernest Han, Susan Higgins, Warner K. Huh, John R. Lurain III, Andrea Mariani, David Mutch, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Fidel A. Valea, Catheryn M. Yashar, Nicole R. McMillian and Jillian L. Scavone

Pages: 1321–1331
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys

By: Razelle Kurzrock, A. Dimitrios Colevas, Anthony Olszanski, Wallace Akerley, Carlos L. Arteaga, William E. Carson III, Jeffrey W. Clark, John F. DiPersio, David S. Ettinger, Robert J. Morgan Jr, Lee S. Schwartzberg, Alan P. Venook, Christopher D. Gocke, Jonathan Tait and F. Marc Stewart

Pages: 1337–1346
The Impact of Insurance Status on Tumor Characteristics and Treatment Selection in Contemporary Patients With Prostate Cancer

By: Nicola Fossati, Daniel P. Nguyen, Quoc-Dien Trinh, Jesse Sammon, Akshay Sood, Alessandro Larcher, Giorgio Guazzoni, Francesco Montorsi, Alberto Briganti, Mani Menon and Firas Abdollah

Pages: 1351–1358
Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival

By: Sujana Movva, Margaret von Mehren, Eric A. Ross and Elizabeth Handorf

Pages: 1366–1374
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices

By: Neelima Denduluri, Debra A. Patt, Yunfei Wang, Menaka Bhor, Xiaoyan Li, Anne M. Favret, Phuong Khanh Morrow, Richard L. Barron, Lina Asmar, Shanmugapriya Saravanan, Yanli Li, Jacob Garcia and Gary H. Lyman

Pages: 1383–1393
Multiple Myeloma, Version 2.2016

By: Kenneth C. Anderson, Melissa Alsina, Djordje Atanackovic, J. Sybil Biermann, Jason C. Chandler, Caitlin Costello, Benjamin Djulbegovic, Henry C. Fung, Cristina Gasparetto, Kelly Godby, Craig Hofmeister, Leona Holmberg, Sarah Holstein, Carol Ann Huff, Adetola Kassim, Amrita Y. Krishnan, Shaji K. Kumar, Michaela Liedtke, Matthew Lunning, Noopur Raje, Seema Singhal, Clayton Smith, George Somlo, Keith Stockerl-Goldstein, Steven P. Treon, Donna Weber, Joachim Yahalom, Dorothy A. Shead and Rashmi Kumar

Pages: 1398–1435
Role of Immune Therapies for Myeloma

By: Jacalyn Rosenblatt and David Avigan

Pages: 1440–1447
Is the Preoperative Setting an Appropriate Platform for Drug Approval in Breast Cancer?

By: Virginia G. Kaklamani and William J. Gradishar

Pages: 1448–1452